Methicillin-resistant Staphylococcus aureus pneumonia in diabetics
Authors:
Open Access
- 20 June 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 132 (12) , 1429-1434
Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) pneumonia is an important issue with significant morbidity and mortality in clinical practice, especially in diabetes mellitus (DM). Studies focusing on S. aureus pneumonia in DM is limited, we sought to make a relatively comprehensive exploration of clinical characteristics, antimicrobial resistance, and risk factors for mortality of S. aureus pneumonia in DM and non-diabetics mellitus (non-DM). Methods: A retrospective study was conducted in Ruijin Hospital from 2014 to 2017. The characteristics of DM and non-DM patients were assessed, including demographics, comorbidities, using of invasive mechanical ventilation, Hemoglobin A1c (HbA1C), confusion, urea, respiratory rate, blood pressure, age ≥65 years (CURB-65) score, length of hospital stay, clinical outcomes, antimicrobial susceptibility. Independent risk factors for mortality were identified by univariate and multivariate logistic regression analysis. Results: A total of 365 patients with S. aureus pneumonia were included in our study, including 144 with DM and 221 non-DM. DM patients were more susceptible to MRSA infection (65.3% vs. 56.1%, P > 0.05), suffered from much severer pneumonia with a higher CURB-65 score, invasive mechanical ventilation rate (46.5% vs. 28.1%, P < 0.01) and mortality rates (30.6% vs. 23.1%, P > 0.05); almost all DM patients had higher antimicrobial resistance than non-DM patients, the DM group had a higher co-infection rate (47.2% vs. 45.7%, P > 0.05), and Acinetobacter baumannii was the most common bacterium in DM, while Klebsiella pneumoniae ranked first in patients with non-DM. Independent risk factors for pneumonia-related mortality were MRSA and CURB-65. Higher HbA1c levels were linked to a higher MRSA infection and co-infection rate and more severe pneumonia, leading to an increase in mortality. Conclusions: DM patients with poor glucose control are more susceptible to MRSA infection. They suffer from higher antimicrobial resistance, a higher co-infection rate, and much severer pneumonia than non-DM. MRSA itself is an independent risk factor for mortality in all patients.Keywords
This publication has 27 references indexed in Scilit:
- Genomic Basis for Methicillin Resistance inStaphylococcus aureusInfection & Chemotherapy, 2013
- Deciphering the Multifactorial Nature of Acinetobacter baumannii PathogenicityPLOS ONE, 2011
- Genome Sequence of a Recently Emerged, Highly Transmissible, Multi-Antibiotic- and Antiseptic-Resistant Variant of Methicillin-Resistant Staphylococcus aureus , Sequence Type 239 (TW)Journal of Bacteriology, 2010
- Diabetes, Glycemic Control, and Risk of Hospitalization With PneumoniaDiabetes Care, 2008
- Risk factor analysis of invasive liver abscess caused by the K1 serotype Klebsiella pneumoniaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Glucose in bronchial aspirates increases the risk of respiratory MRSA in intubated patientsThorax, 2005
- Diabetes mellitus in itself is not a risk factor for antibiotic resistance in Escherichia coli isolated from patients with bacteriuriaDiabetic Medicine, 2004
- Effect of hyperglycaemia on glucose concentration of human nasal secretionsClinical Science, 2004
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureusInfections in France: Emergence of a Single Clone That Produces Panton‐Valentine LeukocidinClinical Infectious Diseases, 2002
- Community-Acquired Klebsiella pneumoniae Bacteremia: Global Differences in Clinical PatternsEmerging Infectious Diseases, 2002